Steris Analyst Ratings
Steris Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | 0.23% | Morgan Stanley | $206 → $225 | Maintains | Equal-Weight |
| 08/03/2023 | 14.93% | Keybanc | $254 → $258 | Maintains | Overweight |
| 08/02/2023 | 6.91% | JMP Securities | → $240 | Reiterates | Market Outperform → Market Outperform |
| 07/25/2023 | 13.15% | Keybanc | $235 → $254 | Maintains | Overweight |
| 07/17/2023 | 11.36% | Stephens & Co. | $240 → $250 | Maintains | Overweight |
| 05/30/2023 | -8.24% | Morgan Stanley | → $206 | Initiates Coverage On | → Equal-Weight |
| 05/12/2023 | -10.91% | Piper Sandler | $197 → $200 | Maintains | Neutral |
| 05/12/2023 | 4.68% | Keybanc | $210 → $235 | Maintains | Overweight |
| 05/11/2023 | 6.91% | JMP Securities | → $240 | Reiterates | Market Outperform → Market Outperform |
| 04/14/2023 | -12.25% | Piper Sandler | $215 → $197 | Downgrades | Overweight → Neutral |
| 02/15/2023 | 6.91% | JMP Securities | $250 → $240 | Maintains | Market Outperform |
| 02/10/2023 | -4.23% | Piper Sandler | $235 → $215 | Maintains | Overweight |
| 02/09/2023 | -2% | Stephens & Co. | → $220 | Maintains | Overweight |
| 11/11/2022 | -6.45% | Keybanc | $240 → $210 | Maintains | Overweight |
| 09/23/2022 | — | Needham | Downgrades | Buy → Hold | |
| 08/04/2022 | 5.57% | Needham | $248 → $237 | Maintains | Buy |
| 08/04/2022 | 6.91% | Keybanc | $256 → $240 | Maintains | Overweight |
| 07/14/2022 | 6.91% | Piper Sandler | → $240 | Initiates Coverage On | → Overweight |
| 05/13/2022 | 10.47% | Needham | $263 → $248 | Maintains | Buy |
| 02/14/2022 | 20.27% | JMP Securities | $250 → $270 | Maintains | Market Outperform |
| 02/10/2022 | 17.15% | Needham | $254 → $263 | Maintains | Buy |
| 11/04/2021 | 20.27% | Stephens & Co. | $255 → $270 | Maintains | Overweight |
| 11/04/2021 | 14.04% | Keybanc | $239 → $256 | Maintains | Overweight |
| 08/11/2021 | 11.36% | Baird | $230 → $250 | Maintains | Outperform |
| 08/11/2021 | 13.59% | Stephens & Co. | $217 → $255 | Maintains | Overweight |
| 08/11/2021 | 6.46% | Keybanc | $227 → $239 | Maintains | Overweight |
| 05/26/2021 | 3.79% | Needham | → $233 | Upgrades | Hold → Buy |
| 05/11/2021 | 4.68% | JMP Securities | $217 → $235 | Maintains | Market Outperform |
| 03/11/2021 | 1.12% | Keybanc | $224 → $227 | Maintains | Overweight |
| 02/04/2021 | -0.22% | Keybanc | → $224 | Upgrades | Sector Weight → Overweight |
| 09/02/2020 | -22.05% | Baird | → $175 | Initiates Coverage On | → Outperform |
| 06/09/2020 | — | Needham | Initiates Coverage On | → Hold | |
| 03/23/2020 | -35.41% | Stephens & Co. | $177 → $145 | Maintains | Overweight |
| 02/12/2020 | -21.15% | Stephens & Co. | $165 → $177 | Maintains | Overweight |
| 07/10/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 05/22/2019 | -33.18% | JMP Securities | $135 → $150 | Maintains | Market Outperform |
| 05/15/2019 | -38.53% | Keybanc | $135 → $138 | Maintains | Overweight |
| 12/06/2018 | -30.06% | Sidoti & Co. | $155 → $157 | Maintains | Buy |
| 11/13/2018 | -41.2% | Keybanc | $120 → $132 | Maintains | Overweight |
| 08/09/2018 | -46.55% | Keybanc | $115 → $120 | Maintains | Overweight |
| 08/09/2018 | -44.32% | JMP Securities | $113 → $125 | Maintains | Market Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 08/03/2023 | 0.23% | 摩根士丹利 | $206→$225 | 維護 | 等重 |
| 08/03/2023 | 14.93% | KeyBanc | $254→$258 | 維護 | 超重 |
| 08/02/2023 | 6.91% | JMP證券 | →$240 | 重申 | 市場表現優於→市場表現 |
| 07/25/2023 | 13.15% | KeyBanc | $235→$254 | 維護 | 超重 |
| 07/17/2023 | 11.36% | 斯蒂芬斯公司 | $240→$250 | 維護 | 超重 |
| 2023年05月30日 | -8.24% | 摩根士丹利 | →$206 | 開始承保 | →等重 |
| 2023年05月12日 | -10.91% | 派珀·桑德勒 | $197→$200 | 維護 | 中性 |
| 2023年05月12日 | 4.68% | KeyBanc | $210→$235 | 維護 | 超重 |
| 2023年05月11日 | 6.91% | JMP證券 | →$240 | 重申 | 市場表現優於→市場表現 |
| 04/14/2023 | -12.25% | 派珀·桑德勒 | $215→$197 | 評級下調 | 超重→中性 |
| 02/15/2023 | 6.91% | JMP證券 | $250→$240 | 維護 | 市場表現強於大盤 |
| 02/10/2023 | -4.23% | 派珀·桑德勒 | $235→$215 | 維護 | 超重 |
| 02/09/2023 | -2% | 斯蒂芬斯公司 | →$220 | 維護 | 超重 |
| 2022年11月11日 | -6.45% | KeyBanc | $240→$210 | 維護 | 超重 |
| 09/23/2022 | - | 李約瑟 | 評級下調 | 購買→Hold | |
| 08/04/2022 | 5.57% | 李約瑟 | $248→$237 | 維護 | 買 |
| 08/04/2022 | 6.91% | KeyBanc | $256→$240 | 維護 | 超重 |
| 07/14/2022 | 6.91% | 派珀·桑德勒 | →$240 | 開始承保 | →超重 |
| 2022年05月13日 | 10.47% | 李約瑟 | $263→$248 | 維護 | 買 |
| 02/14/2022 | 20.27% | JMP證券 | $250→$270 | 維護 | 市場表現強於大盤 |
| 02/10/2022 | 17.15% | 李約瑟 | $254→$263 | 維護 | 買 |
| 11/04/2021 | 20.27% | 斯蒂芬斯公司 | $255→$270 | 維護 | 超重 |
| 11/04/2021 | 14.04% | KeyBanc | $239→$256 | 維護 | 超重 |
| 2021/08/11 | 11.36% | 貝爾德 | $230→$250 | 維護 | 跑贏大盤 |
| 2021/08/11 | 13.59% | 斯蒂芬斯公司 | $217→$255 | 維護 | 超重 |
| 2021/08/11 | 6.46% | KeyBanc | $227→$239 | 維護 | 超重 |
| 2021/05/26 | 3.79% | 李約瑟 | →$233 | 升級 | 持有→購買 |
| 2021/11/05 | 4.68% | JMP證券 | $217→$235 | 維護 | 市場表現強於大盤 |
| 03/11/2021 | 1.12% | KeyBanc | $224→$227 | 維護 | 超重 |
| 02/04/2021 | -0.22% | KeyBanc | →$224 | 升級 | 行業權重→超配 |
| 09/02/2020 | -22.05% | 貝爾德 | →$175 | 開始承保 | →跑贏大盤 |
| 06/09/2020 | - | 李約瑟 | 開始承保 | →保留 | |
| 03/23/2020 | -35.41% | 斯蒂芬斯公司 | $177→$145 | 維護 | 超重 |
| 02/12/2020 | -21.15% | 斯蒂芬斯公司 | $165→$177 | 維護 | 超重 |
| 2019年07月10日 | - | KeyBanc | 評級下調 | 增持→板塊權重 | |
| 2019年05月22日 | -33.18% | JMP證券 | $135→$150 | 維護 | 市場表現強於大盤 |
| 2019年05月15日 | -38.53% | KeyBanc | $135→$138 | 維護 | 超重 |
| 2018年12月06日 | -30.06% | 西多蒂公司 | $155→$157 | 維護 | 買 |
| 2018年11月13日 | -41.2% | KeyBanc | $120→$132 | 維護 | 超重 |
| 2018年08月09日 | -46.55% | KeyBanc | $115→$120 | 維護 | 超重 |
| 2018年08月09日 | -44.32% | JMP證券 | $113→$125 | 維護 | 市場表現強於大盤 |
What is the target price for Steris (STE)?
Steris(STE)的目標價是多少？
The latest price target for Steris (NYSE: STE) was reported by Morgan Stanley on August 3, 2023. The analyst firm set a price target for $225.00 expecting STE to rise to within 12 months (a possible 0.23% upside). 17 analyst firms have reported ratings in the last year.
Steris(紐約證券交易所代碼：STE)的最新目標價是由摩根士丹利於2023年8月3日報道的。這家分析公司將目標價定為225.00美元，預計STE將在12個月內升至(可能上漲0.23%)。過去一年，17家分析公司公佈了評級。
What is the most recent analyst rating for Steris (STE)?
Steris(STE)的最新分析師評級是多少？
The latest analyst rating for Steris (NYSE: STE) was provided by Morgan Stanley, and Steris maintained their equal-weight rating.
對Steris(紐約證券交易所股票代碼：STE)的最新分析師評級由摩根士丹利提供，Steris維持其同等權重評級。
When is the next analyst rating going to be posted or updated for Steris (STE)?
Steris(STE)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Steris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Steris was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Steris的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Steris的上一次評級是在2023年8月3日提交的，所以你應該預計下一次評級將在2024年8月3日左右的某個時候提供。
Is the Analyst Rating Steris (STE) correct?
分析師評級Steris(STE)正確嗎？
While ratings are subjective and will change, the latest Steris (STE) rating was a maintained with a price target of $206.00 to $225.00. The current price Steris (STE) is trading at is $224.49, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的斯特裡斯(STE)評級維持不變，目標價在206.00美元至225.00美元之間。斯特裡斯目前的交易價格為224.49美元，在分析師的預測範圍內。